What did Fisher & Paykel Healthcare Corporation Limited announce?

Fisher & Paykel Healthcare Corporation Limited (NZX: FPH) filed “2026 Annual Shareholders' Meeting Results” with NZX on 25 August 2026, as an agm announcement.

From the announcement:“Results of 2026 Annual Shareholders’ Meeting At Fisher & Paykel Healthcare Corporation Limited’s Annual Shareholders’ Meeting, held in Auckland and online today, shareholders were asked to vote on seven ordinary resolutions.”
When was it filed?
25 August 2026
Where is the original?
NZX announcement
Fisher & Paykel Healthcare Corporation Limited logo

2026 Annual Shareholders' Meeting Results

AGM25 August 2026FPHHealthcare

News Release
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)


25 August 2026


Results of 2026 Annual Shareholders’ Meeting


At Fisher & Paykel Healthcare Corporation Limited’s Annual Shareholders’ Meeting, held in Auckland

and online today, shareholders were asked to vote on seven ordinary resolutions. As required by NZX

Listing Rule 6.1, all voting was conducted by a poll.


The ordinary resolutions passed were:


Resolution 1: To elect Anna Curzon as a Director.

Resolution 2: To authorise the Directors to fix the fees and expenses of the auditor.

Resolution 3: To approve an increase to the maximum aggregate annual remuneration payable to

non-executive directors.

Resolution 4: To approve the grant of discretionary long term variable remuneration instruments to

Lewis Gradon.

Resolution 5: To approve the 2025 Performance Share Rights Plan – North America.

Resolution 6: To approve the 2025 Share Option Plan – North America.

Resolution 7: To approve the Employee Share Rights Plan – North America.


Details of the total number of votes cast in person, online or by a proxy holder are:


Resolution For Against Abstain

1: To elect Anna Curzon as a Director.

439,332,659

99.88%

514,296

0.12%

27,182

2: To authorise the Directors to fix the fees

and expenses of the auditor.

429,021,432

97.54%

10,823,333

2.46%

29,372

3: To approve an increase to the maximum

aggregate annual remuneration payable to

non-executive directors.

352,605,905

80.47%

85,601,037

19.53%

112,884

4: To approve the grant of discretionary

long term variable remuneration

instruments to Lewis Gradon.

429,735,033

97.98%

8,874,134

2.02%

706,131

5: To approve the 2025 Performance Share

Rights Plan – North America.

432,722,619

98.55%

6,386,217

1.45%

765,307

6: To approve the 2025 Share Option Plan

– North America.

431,054,743

98.16%

8,063,344

1.84%

756,056

7: To approve the Employee Share Rights

Plan – North America.

438,797,705

99.93%

326,148

0.07%

750,290


As at the commencement of the meeting, Fisher & Paykel Healthcare Corporation Limited had

587,302,790 total number of voting shares on issue.




Authority for this announcement

Name of person authorised to make this

announcement

Raelene Leonard

General Counsel & Company Secretary

Contact person for this announcement Raelene Leonard

Contact phone number +64 9 610 4803

Contact email address raelene.leonard@fphcare.co.nz

Date of release through MAP 25 August 2026



About Fisher & Paykel Healthcare


Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems

for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The

company’s products are sold in over 120 countries worldwide. For more information, visit our website

www.fphcare.com.



Contacts


Media Investors

Karen Knott

GM Corporate Communications

karen.knott@fphcare.co.nz

+64 21 713 911

Dan Adolph

Head of Investor Relations

daniel.adolph@fphcare.co.nz

+64 22 511 4050

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.